Engineered deaminases as a key component of DNA and RNA editing tools
Article in Molecular Therapy - Nucleic Acids (October 2023)
The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.
Advancing beyond reverse transcriptase inhibitors: The new era of hepatitis B polymerase inhibitors
Article in European Journal of Medicinal Chemistry (May 2023)
Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution
Article in Virology (January 2021)